factor xiii

Poland

Drugs containing this active substance

  • CLUVOT 1250 J.M.

    The medicinal product is used in adults, children, and adolescents for the prophylactic treatment of congenital factor XIII deficiency and for the treatment of bleeding during surgical procedures in patients with this deficiency.

    Form: powder and solvent for solution for injection and infusion

    Active substance Dosage
    factor xiii 1250 j.m. (1000 - 1600 j.m.)

    ATC: B02BD07

    Manufacturer: CSL Behring GmbH

  • CLUVOT 250 J.M.

    The medicinal product is used in adults, children, and adolescents for the prophylactic treatment of congenital factor XIII deficiency and for the treatment of bleeding during surgical procedures in patients with this deficiency.

    Form: powder and solvent for solution for injection and infusion

    Active substance Dosage
    factor xiii 250 IU (200 - 320 IU)

    ATC: B02BD07

    Manufacturer: CSL Behring GmbH